Radio and PodcastLive Radio & PodcastsScience & Medicine
FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause
Listen to an audio podcast of the September 12th, 2024 FDA Drug Safety Communication on rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause.
About This Episode
FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause is an episode from FDA Drug Safety Podcasts by U.S. Food and Drug Administration, Center for Drug Evaluation a...
Podcast
This episode belongs to FDA Drug Safety Podcasts.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Sep 20, 2024, 3:30 long, audio available.
Related Episodes
Continue listening to more episodes from FDA Drug Safety Podcasts.
Questions About This Episode
What is FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause about?
Listen to an audio podcast of the September 12th, 2024 FDA Drug Safety Communication on rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause.
Where can I listen to FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause?
You can listen to FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause from?
FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause is an episode from FDA Drug Safety Podcasts by U.S. Food and Drug Administration, Center for Drug Evaluation and Research.
How long is this episode?
This episode is 3:30 long.
When was this episode published?
This episode was published on Sep 20, 2024.
Can I save FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from FDA Drug Safety Podcasts?
Yes. This page shows related episodes from FDA Drug Safety Podcasts when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause?
You can listen to FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause is from FDA Drug Safety Podcasts by U.S. Food and Drug Administration, Center for Drug Evaluation and Research.
What are the episode details?
Published Sep 20, 2024 and 3:30 long